Terahertz metasensor with pseudo parity time symmetry for oral cancer diagnostics
Figure 2(a-b) represent the absorption and real RI of normal and cancered oral samples at room temperatures. At room…
Early clinical trial supports MASL as a targeted oral cancer treatment
Rowan University and Sentrimed®, a clinical-stage biopharmaceutical company focused on developing safer, orally dosed oncology therapies, today announced…